These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 37175126)

  • 1. The Development of Naringin for Use against Bone and Cartilage Disorders.
    Gan J; Deng X; Le Y; Lai J; Liao X
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinspired bone therapies using naringin: applications and advances.
    Lavrador P; Gaspar VM; Mano JF
    Drug Discov Today; 2018 Jun; 23(6):1293-1304. PubMed ID: 29747006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naringin protects human adipose-derived mesenchymal stem cells against hydrogen peroxide-induced inhibition of osteogenic differentiation.
    Wang L; Zhang YG; Wang XM; Ma LF; Zhang YM
    Chem Biol Interact; 2015 Dec; 242():255-61. PubMed ID: 26482937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naringin promotes osteogenesis and ameliorates osteoporosis development by targeting JAK2/STAT3 signalling.
    Wang W; Mao J; Chen Y; Zuo J; Chen L; Li Y; Gao Y; Lu Q
    Clin Exp Pharmacol Physiol; 2022 Jan; 49(1):113-121. PubMed ID: 34525226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of naringin on the proliferation and osteogenic differentiation of human amniotic fluid-derived stem cells.
    Liu M; Li Y; Yang ST
    J Tissue Eng Regen Med; 2017 Jan; 11(1):276-284. PubMed ID: 24915843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naringin ameliorates bone loss induced by sciatic neurectomy and increases Semaphorin 3A expression in denervated bone.
    Ma X; Lv J; Sun X; Ma J; Xing G; Wang Y; Sun L; Wang J; Li F; Li Y; Zhao Z
    Sci Rep; 2016 Apr; 6():24562. PubMed ID: 27109829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naringin promotes osteoblast differentiation and effectively reverses ovariectomy-associated osteoporosis.
    Li N; Jiang Y; Wooley PH; Xu Z; Yang SY
    J Orthop Sci; 2013 May; 18(3):478-85. PubMed ID: 23553541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of Drynaria fortunei in modulation of BMP–2 signalling by bone tissue engineering.
    Dong GC; Ma TY; Li CH; Chi CY; Su CM; Huang CL; Wang YH; Lee TM
    Turk J Med Sci; 2020 Aug; 50(5):1444-1453. PubMed ID: 32252500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research progress on Drynaria fortunei naringin on inflammation and bone activity].
    Yin FM; Xiao LB; Zhang Y
    Zhongguo Gu Shang; 2015 Feb; 28(2):182-6. PubMed ID: 25924506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-osteoporosis activity of naringin in the retinoic acid-induced osteoporosis model.
    Wei M; Yang Z; Li P; Zhang Y; Sse WC
    Am J Chin Med; 2007; 35(4):663-7. PubMed ID: 17708632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evidence for the pharmacological actions of naringin: a review.
    Bharti S; Rani N; Krishnamurthy B; Arya DS
    Planta Med; 2014 Apr; 80(6):437-51. PubMed ID: 24710903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of naringin: an overview.
    Chen R; Qi QL; Wang MT; Li QY
    Pharm Biol; 2016 Dec; 54(12):3203-3210. PubMed ID: 27564838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naringin prevents ovariectomy-induced osteoporosis and promotes osteoclasts apoptosis through the mitochondria-mediated apoptosis pathway.
    Li F; Sun X; Ma J; Ma X; Zhao B; Zhang Y; Tian P; Li Y; Han Z
    Biochem Biophys Res Commun; 2014 Sep; 452(3):629-35. PubMed ID: 25181344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of Wnt/β-Catenin Signaling to Improve Bone Development by Naringin via Interacting with AMPK and Akt.
    Wang D; Ma W; Wang F; Dong J; Wang D; Sun B; Wang B
    Cell Physiol Biochem; 2015; 36(4):1563-76. PubMed ID: 26159568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation.
    Ang ES; Yang X; Chen H; Liu Q; Zheng MH; Xu J
    FEBS Lett; 2011 Sep; 585(17):2755-62. PubMed ID: 21835177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naringin increases osteoprotegerin expression in fibroblasts from periprosthetic membrane by the Wnt/β-catenin signaling pathway.
    Yang C; Liu W; Zhang X; Zeng B; Qian Y
    J Orthop Surg Res; 2020 Dec; 15(1):600. PubMed ID: 33302980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of naringin on degenerative human nucleus pulposus cells for discogenic low back pain.
    Li N; Whitaker C; Xu Z; Heggeness M; Yang SY
    Spine J; 2016 Oct; 16(10):1231-1237. PubMed ID: 27208552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of periostin-sclerostin-Wnt/β-catenin signaling pathway in the prevention of neurectomy-induced bone loss by naringin.
    Lv J; Sun X; Ma J; Ma X; Xing G; Wang Y; Sun L; Wang J; Li F; Li Y
    Biochem Biophys Res Commun; 2015 Dec; 468(4):587-93. PubMed ID: 26541456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective activity of genistein against bone and cartilage diseases.
    Wu Z; Liu L
    Front Pharmacol; 2022; 13():1016981. PubMed ID: 36160403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naringin Protects Against Cartilage Destruction in Osteoarthritis Through Repression of NF-κB Signaling Pathway.
    Zhao Y; Li Z; Wang W; Zhang H; Chen J; Su P; Liu L; Li W
    Inflammation; 2016 Feb; 39(1):385-392. PubMed ID: 26438631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.